Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 4,531 | 5,198 | 5,538 | 4,339 | 3,805 |
| Gross Profit | 5,370 | 5,220 | 5,530 | 4,330 | 3,800 |
| Operating Expenses | 10,800 | 12,440 | 11,860 | 9,580 | 9,920 |
| Operating Income | -6,269 | -7,242 | -6,322 | -5,241 | -6,115 |
| Interest Expense | 260 | 220 | 110 | 60 | 60 |
| Other Income | 129 | -618 | -558 | -559 | -65 |
| Pre-tax Income | -6,400 | -8,080 | -6,990 | -5,860 | -6,240 |
| Net Income Continuous | -6,406 | -8,070 | -6,992 | -5,865 | -6,243 |
| Net Income | $-6,406 | $-8,070 | $-6,992 | $-5,865 | $-6,243 |
| EPS Basic Total Ops | -10,504.20 | -13,305.32 | -11,204.48 | -9,803.92 | -9,803.92 |
| EPS Basic Continuous Ops | -10,676.67 | -13,450.00 | -11,653.33 | -9,775.00 | -10,405.00 |
| EPS Diluted Total Ops | -10,504.20 | -13,305.32 | -11,204.48 | -9,803.92 | -9,803.92 |
| EPS Diluted Continuous Ops | -10,676.67 | -13,450.00 | -11,653.33 | -9,775.00 | -10,405.00 |
| EBITDA(a) | $-5,309 | $-4,922 | $-4,862 | $-331 | $-6,115 |